Le Lézard
Classified in: Tourism and vacations, Transportation, Health, Covid-19 virus
Subject: AVO

CLIA Statement Regarding CDC Elevating to Level 4 Warning Against Cruise Travel


WASHINGTON, Dec. 30, 2021 /PRNewswire/ -- The decision by the CDC to raise the travel level for cruise is particularly perplexing considering that cases identified on cruise ships consistently make up a very slim minority of the total population onboard?far fewer than on land?and the majority of those cases are asymptomatic or mild in nature, posing little to no burden on medical resources onboard or onshore. No setting can be immune from this virus?however, it is also the case that cruise provides one of the highest levels of demonstrated mitigation against the virus. Cruise ships offer a highly controlled environment with science-backed measures, known testing and vaccination levels far above other venues or modes of transportation and travel, and significantly lower incidence rates than land.

While we are disappointed and disagree with the decision to single out the cruise industry?an industry that continues to go above and beyond compared to other sectors?CLIA and our ocean-going cruise line members remain committed to working collaboratively with the CDC in the interest of public health and safety.

Additional Information:

About the Cruise Lines International Association (CLIA)

CLIA is the world's largest cruise industry trade association, providing a unified voice and leading authority of the global cruise community. On behalf of its members, affiliates, and partners, the organization supports policies and practices that foster a secure, healthy, and sustainable cruise ship environment, promoting positive travel experiences for the more than 30 million passengers who have cruised annually. The CLIA community includes the world's most prestigious ocean, river, and specialty cruise lines; a highly trained and certified travel agent community; and widespread industry stakeholders, including ports & destinations, ship development, suppliers, and business services. CLIA represents 95% of the world's ocean-going cruise capacity, as well as 54,000 travel agents, and 15,000 of the largest travel agencies in the world. The organization's global headquarters are in Washington, DC, with regional offices located in North and South America, Europe, Asia, and Australasia. For more information, please visit cruising.org or follow us on Facebook, Instagram, Twitter, and YouTube with our handle @CLIAGlobal?or on LinkedIn.  

Members of the media, please contact us at [email protected] for more information.

SOURCE Cruise Lines International Association


These press releases may also interest you

3 jui 2024
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. between March 9, 2023 and February 29, 2024, both dates inclusive (the "Class Period"), of the important August 6, 2024 lead plaintiff...

3 jui 2024
The global feminine hygiene wash market  size is estimated to grow by USD 124.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 5.17%  during the forecast period.  Advertising and promotion of...

3 jui 2024
The global marine loading arms market size is estimated to grow by USD 65.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.43%  during the forecast period. Rise in demand for oil and gas...

3 jui 2024
The global payment gateways market size is estimated to grow by USD 11.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 13.42%  during the forecast period.  High adoption of contactless payment...

3 jui 2024
The global wellness real estate market size is estimated to grow by USD 1.26 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 32.14% during the forecast period. Rising demand for wellness real estate from...

3 jui 2024
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the...



News published on and distributed by: